Jim Shaylor, 74, has COPD [chronic obstructive pulmonary disease] - an incurable chronic lung condition affecting more than 1 ...

Ohtuvayre (ensifentrine), a drug approved in 2024 to treat chronic obstructive pulmonary disorder (COPD), is receiving high marks from doctors and patients. Ohtuvayre is the first new inhaled COPD ...

Early identification and treatment of patients with COPD at risk of exacerbation are crucial for better outcomes. Single-inhaler triple therapy (SITT) users showed improved exacerbation rates and ...

Treatment pathways, including escalation and de-escalation of therapy, for patients with COPD are explored by a panel of medical experts. Reynold Panettieri Jr, MD: I tend to escalate pretty [early] ...

David Mannino is co-founder and chief medical officer of the COPD Foundation. He's an internal medicine doctor with a specialty in pulmonary, critical care, and sleep medicine at University of ...

The symptoms of COPD aren’t always obvious. Subtle signs like finding it harder to keep up with friends on a walk or unconsciously cutting down on physical activity can be easy to miss. Some people ...

Advancements in COPD Treatment Options The ongoing development of treatment strategies, such as combination inhalers, biologic treatments, and non-invasive ventilation, is strongly driving the COPD ...

COPD 5-year mortality was most likely in patients receiving long-term oxygen therapy, oral corticosteroids, and triple therapy. Increasing treatment intensity levels (TILs) in patients with chronic ...

With climate change, a recent uptick in wildfires and smog, and increased pollution worldwide, many people are concerned about the quality of their air. In Philly, a city that continues to rank ...

Chronic obstructive pulmonary disease (COPD) treatments involving inhaled corticosteroids (ICSs) were associated with a greater risk for fractures, a meta-analysis of several dozen randomized trials ...